Print Friendly, PDF & Email

NCT/Study#

NCT03924869 /

MK-3475-867

A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Participants With Unresected Stages I or IIA Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)

DISEASE GROUP:
Thoracic (Lung)
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: